Stock Trading Ideas

Fortinet Targets 45% Growth-Margin Combo, $450 Million Refresh Boost: Analysts See Big Upside

Silence Therapeutics' Zerlasiran Has Competitive Concerns: Analyst

Aclaris Stock Soars As Analysts See Fresh Momentum After Strategic Review And Encouraging Promising Pipeline Developments

Silence Therapeutics' Zerlasiran Has Competitive Concerns: Analyst

Aclaris Stock Soars As Analysts See Fresh Momentum After Strategic Review And Encouraging Promising Pipeline Developments

Rocket Pharmaceuticals' Gene Therapy Progress Boosts Confidence in Future Developments: Analyst

Lucid Forms Cross As Gravity SUV, Earnings Show Progress

Rocket Pharmaceuticals' Gene Therapy Progress Boosts Confidence in Future Developments: Analyst

Lucid Forms Cross As Gravity SUV, Earnings Show Progress

Dell Hits A Golden Cross: Can It Power Through Earnings Week?

Microsoft's AI Agents Are Here To Work Hard — But Can They Lift MSFT Stock?

Trading Ideas Recent News

Warner Bros. Discovery NBA Deal 'Best Case Scenario': Analyst Says Renewal Structure Could Boost Annual Profit

Warner Bros. Discovery reaching a deal with the NBA that includes some international rights and licensing of "Inside the NBA" could be a win.

Target Q3 Earnings Preview: Analysts Expect Revenue, EPS Growth As Attention Turns To Holiday Quarter

Target investors and analysts could quickly shift their attention to the current fourth quarter, which includes the holiday shopping season.

Snowflake 'One Of The Most Compelling Stories In Software' Ahead Of Earnings: Analyst

Analyst expects strong performance from big names ahead of Q3 earnings. Palo Alto Networks, Couchbase, and Snowflake remain top picks.

BridgeBio Pharma's Acoramidis Shows Competitive Edge Against Pfizer's Tafamidisa In Lucrative But Competitive ATTR-CM Market

BridgeBio's acoramidis shows significant reductions in mortality and hospitalizations in ATTR-CM patients, with no new safety concerns in long-term studies.

Vertiv's Earnings Estimates Raised By Analyst Amid Improved Margin Outlook

Vertiv's earnings estimates are raised by BofA analyst due to stronger revenue growth and improved margin outlook.

Why Chinese Stocks May Be Ready to Take Off

Investors are losing faith in China, but their market hasn't fallen as much as believed. President Xi's stimulus efforts could improve the situation.

Septerna Poised For Biopharma Breakthrough: Analysts Cite GPCR Innovation And 2025 Milestones

Analysts initiated coverage on Septerna, Inc. with Overweight ratings and price targets of $50 and $38. SEPN's innovative platform and potential pipeline make it a promising biopharma player.

Gold Moves Higher; Medtronic Posts Upbeat Results

A Hedge Fund Hit Big On Trump's Rumored Crypto Acquisition And Could Be Up $14.15 Million

A hedge fund recently disclosed a stake in Bakkt. With reports that Donald Trump's media company could acquire the cryptocurrency company, the stake is up over 100% quickly.

Bitdeer Technologies' Strong Growth Potential Highlighted By Analysts Amid Bitcoin Bull Market

Analysts remain bullish on Bitdeer Technologies, highlighting strong growth potential amid the Bitcoin bull market, despite a dip in Q3 revenue.

Joby Aviation Positioned For Air Taxi Leadership, Thanks To FAA Backing And Uber Partnership: Analyst

Analyst initiates coverage on JOBY with Buy rating and $8 price target. JOBY's partnership with Uber and focus on software position them well in air taxi market.

Walmart's Q3 Performance Shows Structural Gains Fueling Future Growth: Analyst

JP Morgan analyst views Walmart's strong Q3 results, with sales of $169.6B and raised guidance for EPS and sales growth.

Wall Street's Most Accurate Analysts Weigh In On 3 Defensive Stocks With Over 5% Dividend Yields